A Study to Evaluate the Drug-drug Interaction and Safety Between "BR6001-1" and "BR6001-2"

Clinical trial NCT06165237 · COMPLETED

Trial details

NCT number: NCT06165237
Sponsor: Boryung Pharmaceutical Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Gastric or Duodenal Ulcer

Start date: 2023-03-30
Primary completion: 2023-05-09
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.